THE DAY, IN CONTEXTPolaris InsightsAn AI-powered comprehensive news portal

POLARIS INSIGHTS

Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

Key PointsNovo Nordisk maintains high profitability through its specialization in chronic disease management and metabolic health.

Read the original report for the complete account of this story.

More from the Markets desk

More from Markets · Back to Polaris Insights